3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Ischemic Heart Diseases
Ischemic heart diseases often referred to as coronary artery disease, occur when blood flow to the heart is reduced due to narrowed or blocked coronary arteries. This restriction, usually caused by atherosclerosis, deprives the heart muscle of oxygen and nutrients, leading to symptoms like chest pain (angina), fatigue, and shortness of breath. Severe or prolonged ischemia can result in a heart attack, posing life-threatening risks. Managing ischemic heart diseases involves lifestyle changes, medications to improve blood flow, and medical interventions like stenting or bypass surgery. Early diagnosis and treatment play a vital role in preventing complications and improving long-term cardiac health. With ongoing advancements in cardiology, innovative therapies are offering patients new opportunities for recovery and improved quality of life.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain